Celadon Pharmaceuticals 🇬🇧
UK · Est. 2018 · MHRA, EU-GMP, Home Office Schedule 1
Celadon Pharmaceuticals is the UK's first domestic medical cannabis cultivator, growing GMP-grade flower under controlled conditions in the UK. Their products are supplied directly to UK pharmacies and specialist clinics, reducing reliance on imports.
About Celadon Pharmaceuticals
Celadon is one of the UK's first domestic medical cannabis companies, growing pharmaceutical-grade cannabis entirely on British soil. Founded in 2018 following the UK's 2018 legalisation, Celadon operates a purpose-built cultivation facility in Nottinghamshire, England.
Growing cannabis in the UK rather than importing it from Canada or the Netherlands gives Celadon several advantages: lower supply chain risks, faster delivery to UK pharmacies, and a 'British-grown' quality assurance story that resonates with patients and prescribers.
Celadon's products are cultivated under full MHRA oversight and certified to EU-GMP pharmaceutical standards. Their Blue Dream-derived T20 product is a popular prescription on UK clinics, particularly appreciated for its consistent quality and the fact that it supports domestic UK manufacturing.
The UK domestic cannabis industry remains small, but Celadon's work establishing MHRA-compliant cultivation is paving the way for a homegrown medical cannabis sector that could significantly reduce UK patient costs over the next decade.
Certifications & Standards
MHRA, EU-GMP, Home Office Schedule 1